LONDON, July 01, 2022 (GLOBE NEWSWIRE) -- Freeline Therapeutics Holdings plc (Nasdaq:FRLN) today announced that on June 30, 2022, the Company granted a newly hired employee non-statutory options to purchase 5,500 of the Company’s ordinary shares.
Freeline Announces June 2022 Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Globe Newswire - Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here